AstraZeneca Withdraws COVID Vaccine Worldwide Amid Rare Side Effects

The pharmaceutical giant cites commercial reasons for the withdrawal, following admissions of rare but severe side effects.

AstraZeneca admitted that its COVID-19 vaccine can cause Thrombosis with Thrombocytopenia Syndrome (TTS), a condition leading to blood clots and low platelet counts.
Despite the vaccine's withdrawal, AstraZeneca maintains that the benefits of the vaccine outweigh the risks, based on clinical trials and real-world data.
The decision to pull the vaccine will not affect the United States, where it was never approved for market.
Legal battles and compensation claims continue as affected individuals and their families seek justice for injuries linked to the vaccine.
The withdrawal marks a significant shift in the global strategy against COVID-19, with a move towards newer vaccines designed to combat emerging variants.